Cite
MLA Citation
L.H. Sehn et al.. “MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP‐UP DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (NHL).” Hematological oncology, vol. 37, n.d., pp. 310–311. http://access.bl.uk/ark:/81055/vdc_100096867504.0x000037